Celgene (CELG) Says OTEZLA Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis
Tweet Send to a Friend
Celgene Corporation (NASDAQ: CELG) today announced the results of two post hoc sub-analyses of clinical trials for OTEZLA® (apremilast) at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
